The global Haemophilia Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Haemophilia Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Haemophilia Treatment, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Haemophilia Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Haemophilia Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Haemophilia Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Haemophilia Treatment sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Haemophilia Treatment Market Report

Report Metric	Details
Report Name	Haemophilia Treatment Market
CAGR	5%
Segment by Type	Haemophilia A Haemophilia B
Segment by Application	Hospital Pharmaceutical Companies Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda, CSL Behring, Alnylam Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Haemophilia Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Haemophilia Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Haemophilia Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Haemophilia Treatment Market report?

Ans: The main players in the Haemophilia Treatment Market are Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda, CSL Behring, Alnylam Pharmaceuticals

What are the Application segmentation covered in the Haemophilia Treatment Market report?

Ans: The Applications covered in the Haemophilia Treatment Market report are Hospital, Pharmaceutical Companies, Other

What are the Type segmentation covered in the Haemophilia Treatment Market report?

Ans: The Types covered in the Haemophilia Treatment Market report are Haemophilia A, Haemophilia B

1 Study Coverage

1.1 Haemophilia Treatment Product Introduction

1.2 Market by Type

1.2.1 Global Haemophilia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Haemophilia A

1.2.3 Haemophilia B

1.3 Market by Application

1.3.1 Global Haemophilia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Pharmaceutical Companies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Haemophilia Treatment Sales Estimates and Forecasts 2019-2030

2.2 Global Haemophilia Treatment Revenue by Region

2.2.1 Global Haemophilia Treatment Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Haemophilia Treatment Revenue by Region (2019-2024)

2.2.3 Global Haemophilia Treatment Revenue by Region (2025-2030)

2.2.4 Global Haemophilia Treatment Revenue Market Share by Region (2019-2030)

2.3 Global Haemophilia Treatment Sales Estimates and Forecasts 2019-2030

2.4 Global Haemophilia Treatment Sales by Region

2.4.1 Global Haemophilia Treatment Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Haemophilia Treatment Sales by Region (2019-2024)

2.4.3 Global Haemophilia Treatment Sales by Region (2025-2030)

2.4.4 Global Haemophilia Treatment Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Haemophilia Treatment Sales by Manufacturers

3.1.1 Global Haemophilia Treatment Sales by Manufacturers (2019-2024)

3.1.2 Global Haemophilia Treatment Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Haemophilia Treatment in 2023

3.2 Global Haemophilia Treatment Revenue by Manufacturers

3.2.1 Global Haemophilia Treatment Revenue by Manufacturers (2019-2024)

3.2.2 Global Haemophilia Treatment Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Haemophilia Treatment Revenue in 2023

3.3 Global Key Players of Haemophilia Treatment, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Haemophilia Treatment Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Haemophilia Treatment, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Haemophilia Treatment, Product Offered and Application

3.8 Global Key Manufacturers of Haemophilia Treatment, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Haemophilia Treatment Sales by Type

4.1.1 Global Haemophilia Treatment Historical Sales by Type (2019-2024)

4.1.2 Global Haemophilia Treatment Forecasted Sales by Type (2025-2030)

4.1.3 Global Haemophilia Treatment Sales Market Share by Type (2019-2030)

4.2 Global Haemophilia Treatment Revenue by Type

4.2.1 Global Haemophilia Treatment Historical Revenue by Type (2019-2024)

4.2.2 Global Haemophilia Treatment Forecasted Revenue by Type (2025-2030)

4.2.3 Global Haemophilia Treatment Revenue Market Share by Type (2019-2030)

4.3 Global Haemophilia Treatment Price by Type

4.3.1 Global Haemophilia Treatment Price by Type (2019-2024)

4.3.2 Global Haemophilia Treatment Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Haemophilia Treatment Sales by Application

5.1.1 Global Haemophilia Treatment Historical Sales by Application (2019-2024)

5.1.2 Global Haemophilia Treatment Forecasted Sales by Application (2025-2030)

5.1.3 Global Haemophilia Treatment Sales Market Share by Application (2019-2030)

5.2 Global Haemophilia Treatment Revenue by Application

5.2.1 Global Haemophilia Treatment Historical Revenue by Application (2019-2024)

5.2.2 Global Haemophilia Treatment Forecasted Revenue by Application (2025-2030)

5.2.3 Global Haemophilia Treatment Revenue Market Share by Application (2019-2030)

5.3 Global Haemophilia Treatment Price by Application

5.3.1 Global Haemophilia Treatment Price by Application (2019-2024)

5.3.2 Global Haemophilia Treatment Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Haemophilia Treatment Market Size by Type

6.1.1 US & Canada Haemophilia Treatment Sales by Type (2019-2030)

6.1.2 US & Canada Haemophilia Treatment Revenue by Type (2019-2030)

6.2 US & Canada Haemophilia Treatment Market Size by Application

6.2.1 US & Canada Haemophilia Treatment Sales by Application (2019-2030)

6.2.2 US & Canada Haemophilia Treatment Revenue by Application (2019-2030)

6.3 US & Canada Haemophilia Treatment Market Size by Country

6.3.1 US & Canada Haemophilia Treatment Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Haemophilia Treatment Sales by Country (2019-2030)

6.3.3 US & Canada Haemophilia Treatment Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Haemophilia Treatment Market Size by Type

7.1.1 Europe Haemophilia Treatment Sales by Type (2019-2030)

7.1.2 Europe Haemophilia Treatment Revenue by Type (2019-2030)

7.2 Europe Haemophilia Treatment Market Size by Application

7.2.1 Europe Haemophilia Treatment Sales by Application (2019-2030)

7.2.2 Europe Haemophilia Treatment Revenue by Application (2019-2030)

7.3 Europe Haemophilia Treatment Market Size by Country

7.3.1 Europe Haemophilia Treatment Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Haemophilia Treatment Sales by Country (2019-2030)

7.3.3 Europe Haemophilia Treatment Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Haemophilia Treatment Market Size

8.1.1 China Haemophilia Treatment Sales (2019-2030)

8.1.2 China Haemophilia Treatment Revenue (2019-2030)

8.2 China Haemophilia Treatment Market Size by Application

8.2.1 China Haemophilia Treatment Sales by Application (2019-2030)

8.2.2 China Haemophilia Treatment Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Haemophilia Treatment Market Size by Type

9.1.1 Asia Haemophilia Treatment Sales by Type (2019-2030)

9.1.2 Asia Haemophilia Treatment Revenue by Type (2019-2030)

9.2 Asia Haemophilia Treatment Market Size by Application

9.2.1 Asia Haemophilia Treatment Sales by Application (2019-2030)

9.2.2 Asia Haemophilia Treatment Revenue by Application (2019-2030)

9.3 Asia Haemophilia Treatment Sales by Region

9.3.1 Asia Haemophilia Treatment Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Haemophilia Treatment Revenue by Region (2019-2030)

9.3.3 Asia Haemophilia Treatment Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Haemophilia Treatment Market Size by Type

10.1.1 Middle East, Africa and Latin America Haemophilia Treatment Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Haemophilia Treatment Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Haemophilia Treatment Market Size by Application

10.2.1 Middle East, Africa and Latin America Haemophilia Treatment Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Haemophilia Treatment Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Haemophilia Treatment Sales by Country

10.3.1 Middle East, Africa and Latin America Haemophilia Treatment Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Haemophilia Treatment Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Haemophilia Treatment Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Bayer

11.1.1 Bayer Company Information

11.1.2 Bayer Overview

11.1.3 Bayer Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Bayer Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Bayer Recent Developments

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Information

11.2.2 Novo Nordisk Overview

11.2.3 Novo Nordisk Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Novo Nordisk Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novo Nordisk Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Information

11.3.2 Pfizer Overview

11.3.3 Pfizer Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Pfizer Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Pfizer Recent Developments

11.4 Roche

11.4.1 Roche Company Information

11.4.2 Roche Overview

11.4.3 Roche Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Roche Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Roche Recent Developments

11.5 Aptevo Therapeutics

11.5.1 Aptevo Therapeutics Company Information

11.5.2 Aptevo Therapeutics Overview

11.5.3 Aptevo Therapeutics Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Aptevo Therapeutics Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Aptevo Therapeutics Recent Developments

11.6 Catalyst BioSciences

11.6.1 Catalyst BioSciences Company Information

11.6.2 Catalyst BioSciences Overview

11.6.3 Catalyst BioSciences Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Catalyst BioSciences Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Catalyst BioSciences Recent Developments

11.7 Dimension Therapeutics

11.7.1 Dimension Therapeutics Company Information

11.7.2 Dimension Therapeutics Overview

11.7.3 Dimension Therapeutics Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Dimension Therapeutics Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Dimension Therapeutics Recent Developments

11.8 Takeda

11.8.1 Takeda Company Information

11.8.2 Takeda Overview

11.8.3 Takeda Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Takeda Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Takeda Recent Developments

11.9 CSL Behring

11.9.1 CSL Behring Company Information

11.9.2 CSL Behring Overview

11.9.3 CSL Behring Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 CSL Behring Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 CSL Behring Recent Developments

11.10 Alnylam Pharmaceuticals

11.10.1 Alnylam Pharmaceuticals Company Information

11.10.2 Alnylam Pharmaceuticals Overview

11.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Alnylam Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Haemophilia Treatment Industry Chain Analysis

12.2 Haemophilia Treatment Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Haemophilia Treatment Production Mode & Process

12.4 Haemophilia Treatment Sales and Marketing

12.4.1 Haemophilia Treatment Sales Channels

12.4.2 Haemophilia Treatment Distributors

12.5 Haemophilia Treatment Customers

13 Market Dynamics

13.1 Haemophilia Treatment Industry Trends

13.2 Haemophilia Treatment Market Drivers

13.3 Haemophilia Treatment Market Challenges

13.4 Haemophilia Treatment Market Restraints

14 Key Findings in The Global Haemophilia Treatment Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Dimension Therapeutics

Takeda

CSL Behring

Alnylam Pharmaceuticals

List of Tables

Table 1. Global Haemophilia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Haemophilia A

Table 3. Major Manufacturers of Haemophilia B

Table 4. Global Haemophilia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Haemophilia Treatment Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Haemophilia Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Haemophilia Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Haemophilia Treatment Revenue Market Share by Region (2019-2024)

Table 9. Global Haemophilia Treatment Revenue Market Share by Region (2025-2030)

Table 10. Global Haemophilia Treatment Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Haemophilia Treatment Sales by Region (2019-2024) & (K Units)

Table 12. Global Haemophilia Treatment Sales by Region (2025-2030) & (K Units)

Table 13. Global Haemophilia Treatment Sales Market Share by Region (2019-2024)

Table 14. Global Haemophilia Treatment Sales Market Share by Region (2025-2030)

Table 15. Global Haemophilia Treatment Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Haemophilia Treatment Sales Share by Manufacturers (2019-2024)

Table 17. Global Haemophilia Treatment Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Haemophilia Treatment Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Haemophilia Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Haemophilia Treatment Price by Manufacturers 2019-2024 (USD/Unit)

Table 21. Global Haemophilia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Haemophilia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Treatment as of 2023)

Table 23. Global Key Manufacturers of Haemophilia Treatment, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Haemophilia Treatment, Product Offered and Application

Table 25. Global Key Manufacturers of Haemophilia Treatment, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Haemophilia Treatment Sales by Type (2019-2024) & (K Units)

Table 28. Global Haemophilia Treatment Sales by Type (2025-2030) & (K Units)

Table 29. Global Haemophilia Treatment Sales Share by Type (2019-2024)

Table 30. Global Haemophilia Treatment Sales Share by Type (2025-2030)

Table 31. Global Haemophilia Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Haemophilia Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Haemophilia Treatment Revenue Share by Type (2019-2024)

Table 34. Global Haemophilia Treatment Revenue Share by Type (2025-2030)

Table 35. Haemophilia Treatment Price by Type (2019-2024) & (USD/Unit)

Table 36. Global Haemophilia Treatment Price Forecast by Type (2025-2030) & (USD/Unit)

Table 37. Global Haemophilia Treatment Sales by Application (2019-2024) & (K Units)

Table 38. Global Haemophilia Treatment Sales by Application (2025-2030) & (K Units)

Table 39. Global Haemophilia Treatment Sales Share by Application (2019-2024)

Table 40. Global Haemophilia Treatment Sales Share by Application (2025-2030)

Table 41. Global Haemophilia Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Haemophilia Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Haemophilia Treatment Revenue Share by Application (2019-2024)

Table 44. Global Haemophilia Treatment Revenue Share by Application (2025-2030)

Table 45. Haemophilia Treatment Price by Application (2019-2024) & (USD/Unit)

Table 46. Global Haemophilia Treatment Price Forecast by Application (2025-2030) & (USD/Unit)

Table 47. US & Canada Haemophilia Treatment Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Haemophilia Treatment Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Haemophilia Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Haemophilia Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Haemophilia Treatment Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Haemophilia Treatment Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Haemophilia Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Haemophilia Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Haemophilia Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Haemophilia Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Haemophilia Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Haemophilia Treatment Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Haemophilia Treatment Sales by Country (2025-2030) & (K Units)

Table 60. Europe Haemophilia Treatment Sales by Type (2019-2024) & (K Units)

Table 61. Europe Haemophilia Treatment Sales by Type (2025-2030) & (K Units)

Table 62. Europe Haemophilia Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Haemophilia Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Haemophilia Treatment Sales by Application (2019-2024) & (K Units)

Table 65. Europe Haemophilia Treatment Sales by Application (2025-2030) & (K Units)

Table 66. Europe Haemophilia Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Haemophilia Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Haemophilia Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Haemophilia Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Haemophilia Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Haemophilia Treatment Sales by Country (2019-2024) & (K Units)

Table 72. Europe Haemophilia Treatment Sales by Country (2025-2030) & (K Units)

Table 73. China Haemophilia Treatment Sales by Type (2019-2024) & (K Units)

Table 74. China Haemophilia Treatment Sales by Type (2025-2030) & (K Units)

Table 75. China Haemophilia Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Haemophilia Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Haemophilia Treatment Sales by Application (2019-2024) & (K Units)

Table 78. China Haemophilia Treatment Sales by Application (2025-2030) & (K Units)

Table 79. China Haemophilia Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Haemophilia Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Haemophilia Treatment Sales by Type (2019-2024) & (K Units)

Table 82. Asia Haemophilia Treatment Sales by Type (2025-2030) & (K Units)

Table 83. Asia Haemophilia Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Haemophilia Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Haemophilia Treatment Sales by Application (2019-2024) & (K Units)

Table 86. Asia Haemophilia Treatment Sales by Application (2025-2030) & (K Units)

Table 87. Asia Haemophilia Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Haemophilia Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Haemophilia Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Haemophilia Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Haemophilia Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Haemophilia Treatment Sales by Region (2019-2024) & (K Units)

Table 93. Asia Haemophilia Treatment Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Haemophilia Treatment Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Haemophilia Treatment Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Haemophilia Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Haemophilia Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Haemophilia Treatment Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Haemophilia Treatment Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Haemophilia Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Haemophilia Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Haemophilia Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Haemophilia Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Haemophilia Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Haemophilia Treatment Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Haemophilia Treatment Sales by Country (2025-2030) & (K Units)

Table 107. Bayer Company Information

Table 108. Bayer Description and Major Businesses

Table 109. Bayer Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Bayer Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Bayer Recent Developments

Table 112. Novo Nordisk Company Information

Table 113. Novo Nordisk Description and Major Businesses

Table 114. Novo Nordisk Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Novo Nordisk Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Novo Nordisk Recent Developments

Table 117. Pfizer Company Information

Table 118. Pfizer Description and Major Businesses

Table 119. Pfizer Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Pfizer Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Pfizer Recent Developments

Table 122. Roche Company Information

Table 123. Roche Description and Major Businesses

Table 124. Roche Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Roche Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Roche Recent Developments

Table 127. Aptevo Therapeutics Company Information

Table 128. Aptevo Therapeutics Description and Major Businesses

Table 129. Aptevo Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. Aptevo Therapeutics Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Aptevo Therapeutics Recent Developments

Table 132. Catalyst BioSciences Company Information

Table 133. Catalyst BioSciences Description and Major Businesses

Table 134. Catalyst BioSciences Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 135. Catalyst BioSciences Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Catalyst BioSciences Recent Developments

Table 137. Dimension Therapeutics Company Information

Table 138. Dimension Therapeutics Description and Major Businesses

Table 139. Dimension Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 140. Dimension Therapeutics Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Dimension Therapeutics Recent Developments

Table 142. Takeda Company Information

Table 143. Takeda Description and Major Businesses

Table 144. Takeda Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 145. Takeda Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Takeda Recent Developments

Table 147. CSL Behring Company Information

Table 148. CSL Behring Description and Major Businesses

Table 149. CSL Behring Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 150. CSL Behring Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. CSL Behring Recent Developments

Table 152. Alnylam Pharmaceuticals Company Information

Table 153. Alnylam Pharmaceuticals Description and Major Businesses

Table 154. Alnylam Pharmaceuticals Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 155. Alnylam Pharmaceuticals Haemophilia Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Alnylam Pharmaceuticals Recent Developments

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Haemophilia Treatment Distributors List

Table 160. Haemophilia Treatment Customers List

Table 161. Haemophilia Treatment Market Trends

Table 162. Haemophilia Treatment Market Drivers

Table 163. Haemophilia Treatment Market Challenges

Table 164. Haemophilia Treatment Market Restraints

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Haemophilia Treatment Product Picture

Figure 2. Global Haemophilia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Haemophilia Treatment Market Share by Type in 2023 & 2030

Figure 4. Haemophilia A Product Picture

Figure 5. Haemophilia B Product Picture

Figure 6. Global Haemophilia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Haemophilia Treatment Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Pharmaceutical Companies

Figure 10. Other

Figure 11. Haemophilia Treatment Report Years Considered

Figure 12. Global Haemophilia Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Haemophilia Treatment Revenue 2019-2030 (US$ Million)

Figure 14. Global Haemophilia Treatment Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Haemophilia Treatment Revenue Market Share by Region (2019-2030)

Figure 16. Global Haemophilia Treatment Sales 2019-2030 ((K Units)

Figure 17. Global Haemophilia Treatment Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Haemophilia Treatment Sales YoY (2019-2030) & (K Units)

Figure 19. US & Canada Haemophilia Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Haemophilia Treatment Sales YoY (2019-2030) & (K Units)

Figure 21. Europe Haemophilia Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Haemophilia Treatment Sales YoY (2019-2030) & (K Units)

Figure 23. China Haemophilia Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Haemophilia Treatment Sales YoY (2019-2030) & (K Units)

Figure 25. Asia (excluding China) Haemophilia Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Haemophilia Treatment Sales YoY (2019-2030) & (K Units)

Figure 27. Middle East, Africa and Latin America Haemophilia Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Haemophilia Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Haemophilia Treatment in the World: Market Share by Haemophilia Treatment Revenue in 2023

Figure 30. Global Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Haemophilia Treatment Sales Market Share by Type (2019-2030)

Figure 32. Global Haemophilia Treatment Revenue Market Share by Type (2019-2030)

Figure 33. Global Haemophilia Treatment Sales Market Share by Application (2019-2030)

Figure 34. Global Haemophilia Treatment Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Haemophilia Treatment Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Haemophilia Treatment Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Haemophilia Treatment Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Haemophilia Treatment Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Haemophilia Treatment Revenue Share by Country (2019-2030)

Figure 40. US & Canada Haemophilia Treatment Sales Share by Country (2019-2030)

Figure 41. U.S. Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Haemophilia Treatment Sales Market Share by Type (2019-2030)

Figure 44. Europe Haemophilia Treatment Revenue Market Share by Type (2019-2030)

Figure 45. Europe Haemophilia Treatment Sales Market Share by Application (2019-2030)

Figure 46. Europe Haemophilia Treatment Revenue Market Share by Application (2019-2030)

Figure 47. Europe Haemophilia Treatment Revenue Share by Country (2019-2030)

Figure 48. Europe Haemophilia Treatment Sales Share by Country (2019-2030)

Figure 49. Germany Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 50. France Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 54. China Haemophilia Treatment Sales Market Share by Type (2019-2030)

Figure 55. China Haemophilia Treatment Revenue Market Share by Type (2019-2030)

Figure 56. China Haemophilia Treatment Sales Market Share by Application (2019-2030)

Figure 57. China Haemophilia Treatment Revenue Market Share by Application (2019-2030)

Figure 58. Asia Haemophilia Treatment Sales Market Share by Type (2019-2030)

Figure 59. Asia Haemophilia Treatment Revenue Market Share by Type (2019-2030)

Figure 60. Asia Haemophilia Treatment Sales Market Share by Application (2019-2030)

Figure 61. Asia Haemophilia Treatment Revenue Market Share by Application (2019-2030)

Figure 62. Asia Haemophilia Treatment Revenue Share by Region (2019-2030)

Figure 63. Asia Haemophilia Treatment Sales Share by Region (2019-2030)

Figure 64. Japan Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 68. India Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Haemophilia Treatment Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Haemophilia Treatment Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Haemophilia Treatment Sales Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Haemophilia Treatment Revenue Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Haemophilia Treatment Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Haemophilia Treatment Sales Share by Country (2019-2030)

Figure 75. Brazil Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Haemophilia Treatment Revenue (2019-2030) & (US$ Million)

Figure 80. Haemophilia Treatment Value Chain

Figure 81. Haemophilia Treatment Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-1K6224

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Hunter Syndrome Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-20H5934

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Haemophilia Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-36J7207

Thu Dec 26 00:00:00 UTC 2024

Add to Cart

Global Sickle Cell Disease Diagnosis Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-7X6185

Fri Dec 20 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Haemophilia Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-36J7207

Global Haemophilia Treatment Market Insights, Forecast to 2030

FEATURED COMPANIES

Haemophilia Treatment Market Size

Haemophilia Treatment Market

Scope of Haemophilia Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Haemophilia Treatment Market report?

What are the Application segmentation covered in the Haemophilia Treatment Market report?

What are the Type segmentation covered in the Haemophilia Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS